Advertisement

Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study

Published:January 13, 2017DOI:https://doi.org/10.1016/j.jacl.2016.12.013

      Highlights

      • Relations between red blood cell fatty acids and total mortality were studied in 6501 women.
      • Multivariable adjusted odds ratios per 1 standard deviation increase in fatty acid levels were calculated.
      • There was an 8% reduction in risk associated with higher eicosapentaenoic acid plus docosahexaenoic acid levels.
      • Red blood cell omega-3 fatty acid content is a significant predictor of all-cause mortality.

      Background

      The prognostic value of circulating polyunsaturated fatty acid (PUFA) levels is unclear.

      Objectives

      To determine the associations between red blood cell (RBC) PUFA levels and risk for death.

      Methods

      This prospective cohort study included 6501 women aged 65 to 80 years who participated in the Women's Health Initiative Memory Study (enrolment began 1996). RBC PUFA levels were measured at baseline and expressed as a percent of total RBC PUFAs. PUFAs of primary interest were the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and their sum (the Omega-3 Index). PUFAs of secondary interest included the 2 major n-6 PUFAs, linoleic acid and arachidonic acid, and the PUFA factor score (a calculated variable including 6 PUFAs that accounts for their intercorrelations). The primary outcome was total mortality through August 2014.

      Results

      After a median of 14.9 years of follow-up, 1851 women (28.5%) had died. RBC levels of EPA and DHA were higher in the survivors (P < .002 for each). In the fully adjusted models, the hazard ratios (99% confidence intervals) for mortality associated with a 1 standard deviation PUFA increase for total mortality were 0.92 (0.85, 0.98) for the Omega-3 Index, 0.89 (0.82, 0.96) for EPA, 0.93 (0.87, 1.0) for DHA, and 0.76 (0.64, 0.90) for the PUFA factor score. There were no significant associations of alpha-linolenic acid, arachidonic acid or linoleic acid with total mortality.

      Conclusions

      Higher RBC levels of marine n-3 PUFAs were associated with reduced risk for all-cause mortality. These findings support the beneficial relationship between the Omega-3 Index and health outcomes.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Itomura M.
        • Fujioka S.
        • Hamazaki K.
        • et al.
        Factors influencing EPA+DHA levels in red blood cells in Japan.
        In Vivo. 2008; 22: 131-135
        • Ogura T.
        • Takada H.
        • Okuno M.
        • et al.
        Fatty acid composition of plasma, erythrocytes and adipose: their correlations and effects of age and sex.
        Lipids. 2010; 45: 137-144
        • CIA
        Country Comparison of Life Expectancy at Birth.
        2011 (Available at: https://www.cia.gov/library/publications/resources/the-world-factbook/rankorder/2102rank.html. Accessed February 1, 2017)
        • Pottala J.V.
        • Garg S.
        • Cohen B.E.
        • Whooley M.A.
        • Harris W.S.
        Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul Study.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 406-412
        • Harris W.S.
        • von Schacky C.
        The Omega-3 Index: a new risk factor for death from coronary heart disease?.
        Prev Med. 2004; 39: 212-220
        • Farzaneh-Far R.
        • Lin J.
        • Epel E.S.
        • Harris W.S.
        • Blackburn E.H.
        • Whooley M.A.
        Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.
        JAMA. 2010; 303: 250-257
        • Wu J.H.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.
        Circulation. 2014; 130: 1245-1253
        • Warensjo E.
        • Sundstrom J.
        • Vessby B.
        • Cederholm T.
        • Riserus U.
        Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study.
        Am J Clin Nutr. 2008; 88: 203-209
        • Laaksonen D.E.
        • Nyyssonen K.
        • Niskanen L.
        • Rissanen T.H.
        • Salonen J.T.
        Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids.
        Arch Intern Med. 2005; 165: 193-199
        • Mozaffarian D.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
        Ann Intern Med. 2013; 158: 515-525
        • Lindberg M.
        • Saltvedt I.
        • Sletvold O.
        • Bjerve K.S.
        Long-chain n-3 fatty acids and mortality in elderly patients.
        Am J Clin Nutr. 2008; 88: 722-729
        • Harris W.S.
        • Kennedy K.F.
        • O'Keefe Jr., J.H.
        • Spertus J.A.
        Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction.
        Int J Cardiol. 2013; 168: 53-59
        • Chien K.L.
        • Lin H.J.
        • Hsu H.C.
        • et al.
        Comparison of predictive performance of various fatty acids for the risk of cardiovascular disease events and all-cause deaths in a community-based cohort.
        Atherosclerosis. 2013; 230: 140-147
        • Marklund M.
        • Leander K.
        • Vikstrom M.
        • et al.
        Polyunsaturated fat intake estimated by circulating biomarkers and risk of cardiovascular disease and all-cause mortality in a population-based cohort of 60-year-old men and women.
        Circulation. 2015; 132: 586-594
        • Eide I.A.
        • Jenssen T.
        • Hartmann A.
        • et al.
        The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.
        Clin J Am Soc Nephrol. 2015; 10: 1246-1256
        • Kleber M.E.
        • Delgado G.E.
        • Lorkowski S.
        • Marz W.
        • von Schacky C.
        Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study.
        Atherosclerosis. 2016; 252: 175-181
        • Pottala J.V.
        • Yaffe K.
        • Robinson J.G.
        • Espeland M.A.
        • Wallace R.
        • Harris W.S.
        Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study.
        Neurology. 2014; 82: 435-442
        • Ammann E.M.
        • Pottala J.V.
        • Harris W.S.
        • et al.
        Omega-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA.
        Neurology. 2013; 81: 1484-1491
        • Persons J.E.
        • Robinson J.G.
        • Ammann E.M.
        • et al.
        Omega-3 fatty acid biomarkers and subsequent depressive symptoms.
        Int J Geriatr Psychiatry. 2014; 29: 747-757
        • Bazinet R.P.
        • Chu M.W.
        Omega-6 polyunsaturated fatty acids: is a broad cholesterol-lowering health claim appropriate?.
        CMAJ. 2014; 186: 434-439
        • Shumaker S.A.
        • Reboussin B.A.
        • Espeland M.A.
        • et al.
        The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.
        Control Clin Trials. 1998; 19: 604-621
        • Pottala J.V.
        • Espeland M.A.
        • Polreis J.
        • Robinson J.
        • Harris W.S.
        Correcting the effects of -20 degrees C storage and aliquot size on erythrocyte fatty acid content in the Women's Health Initiative.
        Lipids. 2012; 47: 835-846
        • Curb J.D.
        • McTiernan A.
        • Heckbert S.R.
        • et al.
        Outcomes ascertainment and adjudication methods in the Women's Health Initiative.
        Ann Epidemiol. 2003; 13: S122-S128
        • Pottala J.V.
        • Djira G.D.
        • Espeland M.A.
        • Ye J.
        • Larson M.G.
        • Harris W.S.
        Structural equation modeling for analyzing erythrocyte fatty acids in Framingham.
        Comput Math Methods Med. 2014; 2014: 160520
        • Browning L.M.
        • Walker C.G.
        • Mander A.P.
        • et al.
        Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.
        Am J Clin Nutr. 2012; 96: 748-758
        • Del Gobbo L.C.
        • Imamura F.
        • Aslibekyan S.
        • et al.
        Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies.
        JAMA Intern Med. 2016; 176: 1155-1166
        • Mozaffarian D.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Circulating long-chain omega-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.
        Ann Intern Med. 2011; 155: 160-170
        • Sala-Vila A.
        • Guasch-Ferre M.
        • Hu F.B.
        • et al.
        Dietary alpha-linolenic acid, marine omega-3 fatty acids, and mortality in a population with high fish consumption: findings from the PREvencion con DIeta MEDiterranea (PREDIMED) study.
        J Am Heart Assoc. 2016; : 5, e002543
        • Harris W.S.
        • Poston W.C.
        • Haddock C.K.
        Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events.
        Atherosclerosis. 2007; 193: 1-10
        • Harris W.S.
        The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses.
        Curr Atheroscler Rep. 2006; 8: 453-459
        • Chowdhury R.
        • Warnakula S.
        • Kunutsor S.
        • et al.
        Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
        Ann Intern Med. 2014; 160: 398-406
        • Folsom A.R.
        • Demissie Z.
        Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women.
        Am J Epidemiol. 2004; 160: 1005-1010
        • Engeset D.
        • Braaten T.
        • Teucher B.
        • et al.
        Fish consumption and mortality in the European Prospective Investigation into Cancer and Nutrition cohort.
        Eur J Epidemiol. 2015; 30: 57-70
        • Bell G.A.
        • Kantor E.D.
        • Lampe J.W.
        • Kristal A.R.
        • Heckbert S.R.
        • White E.
        Intake of long-chain omega-3 fatty acids from diet and supplements in relation to mortality.
        Am J Epidemiol. 2014; 179: 710-720
        • Balk E.M.
        • Lichtenstein A.H.
        • Chung M.
        • Kupelnick B.
        • Chew P.
        • Lau J.
        Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.
        Atherosclerosis. 2006; 189: 19-30
        • Geleijnse J.M.
        • Giltay E.J.
        • Grobbee D.E.
        • Donders A.R.
        • Kok F.J.
        Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials.
        J Hypertens. 2002; 20: 1493-1499
        • Violi F.
        • Pignatelli P.
        • Basili S.
        Nutrition, supplements, and vitamins in platelet function and bleeding.
        Circulation. 2010; 121: 1033-1044
        • Mozaffarian D.
        • Geelen A.
        • Brouwer I.A.
        • Geleijnse J.M.
        • Zock P.L.
        • Katan M.B.
        Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials.
        Circulation. 2005; 112: 1945-1952
        • Rauch B.
        • Senges J.
        The effects of supplementation with omega-3 polyunsaturated fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends.
        Front Physiol. 2012; 3: 1-9
        • Fontes J.D.
        • Rahman F.
        • Lacey S.
        • et al.
        Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort.
        Atherosclerosis. 2015; 240: 431-436
        • Li K.
        • Huang T.
        • Zheng J.
        • Wu K.
        • Li D.
        Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor alpha: a meta-analysis.
        PLoS One. 2014; 9: e88103
        • Cawood A.L.
        • Ding R.
        • Napper F.L.
        • et al.
        Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.
        Atherosclerosis. 2010; 212: 252-259
        • Thies F.
        • Garry J.M.
        • Yaqoob P.
        • et al.
        Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.
        Lancet. 2003; 361: 477-485
        • Pase M.P.
        • Grima N.A.
        • Sarris J.
        Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials.
        Br J Nutr. 2011; 106: 974-980
        • Flock M.R.
        • Skulas-Ray A.C.
        • Harris W.S.
        • Etherton T.D.
        • Fleming J.A.
        • Kris-Etherton P.M.
        Determinants of erythrocyte omega-3 fatty Acid content in response to fish oil supplementation: a dose-response randomized controlled trial.
        J Am Heart Assoc. 2013; 2: e000513
        • Iso H.
        • Kobayashi M.
        • Ishihara J.
        • et al.
        Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I.
        Circulation. 2006; 113: 195-202
        • Investigators G.-H.
        Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
        Lancet. 2008; 372: 1223-1230
        • Marchioli R.
        • Barzi F.
        • Bomba E.
        • et al.
        Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
        Circulation. 2002; 105: 1897-1903
        • Burr M.L.
        • Fehily A.M.
        • Gilbert J.F.
        • et al.
        Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).
        Lancet. 1989; 2: 757-761
        • Rauch B.
        • Schiele R.
        • Schneider S.
        • et al.
        OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
        Circulation. 2010; 122: 2152-2159
        • Bosch J.
        • Gerstein H.C.
        • Dagenais G.R.
        • et al.
        n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
        N Engl J Med. 2012; 367: 309-318
        • Roncaglioni M.C.
        • Tombesi M.
        • Avanzini F.
        • et al.
        n-3 fatty acids in patients with multiple cardiovascular risk factors.
        N Engl J Med. 2013; 368: 1800-1808
        • Harris W.S.
        • Sands S.A.
        • Windsor S.L.
        • et al.
        Omega-3 fatty acids in cardiac biopsies from heart transplant patients: correlation with erythrocytes and response to supplementation.
        Circulation. 2004; 110: 1645-1649
        • Gurzell E.A.
        • Wiesinger J.A.
        • Morkam C.
        • Hemmrich S.
        • Harris W.S.
        • Fenton J.I.
        Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA+DHA content?.
        Prostaglandins Leukot Essent Fatty Acids. 2014; 91: 87-96
        • Metcalf R.G.
        • Cleland L.G.
        • Gibson R.A.
        • et al.
        Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery.
        Am J Clin Nutr. 2010; 91: 528-534
        • Rauch B.
        • Schiele R.
        • Schneider S.
        • et al.
        Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study.
        Cardiovasc Drugs Ther. 2010; 20: 365-375
        • Galan P.
        • Kesse-Guyot E.
        • Czernichow S.
        • Briancon S.
        • Blacher J.
        • Hercberg S.
        Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
        BMJ. 2010; 341: c6273
        • Eussen S.R.
        • Geleijnse J.M.
        • Giltay E.J.
        • Rompelberg C.J.
        • Klungel O.H.
        • Kromhout D.
        Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.
        Eur Heart J. 2012; 33: 1582-1588
        • Harris W.S.
        Are n-3 fatty acids still cardioprotective?.
        Curr Opin Clin Nutr Metab Care. 2013; 16: 141-149
        • Deckelbaum R.J.
        • Calder P.C.
        Different outcomes for omega-3 heart trials: why?.
        Curr Opin Clin Nutr Metab Care. 2012; 15: 97-98
        • Manson J.E.
        • Bassuk S.S.
        • Lee I.M.
        • et al.
        The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
        Contemp Clin Trials. 2012; 33: 159-171
        • Bowen K.J.
        • Harris W.S.
        • Kris-Etherton P.M.
        Omega-3 fatty acids and cardiovascular disease: are there benefits?.
        Curr Treat Options Cardiovasc Med. 2016; 18: 69
        • Harris W.S.
        • Thomas R.M.
        Biological variability of blood omega-3 biomarkers.
        Clin Biochem. 2010; 43: 338-340
        • Virtanen J.K.
        • Mursu J.
        • Voutilainen S.
        • Uusitupa M.
        • Tuomainen T.P.
        Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the kuopio ischemic heart disease risk factor study.
        Diabetes Care. 2014; 37: 189-196
        • de Oliveira Otto M.C.
        • Wu J.H.
        • Baylin A.
        • et al.
        Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the multi-ethnic study of atherosclerosis.
        J Am Heart Assoc. 2013; 2: e000506
        • Zhang J.Y.
        • Kothapalli K.S.
        • Brenna J.T.
        Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis.
        Curr Opin Clin Nutr Metab Care. 2016; 19: 103-110
        • Tintle N.L.
        • Pottala J.V.
        • Lacey S.
        • et al.
        A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study.
        Prostaglandins Leukot Essent Fatty Acids. 2015; 94: 65-72
        • Harris W.S.
        • Kennedy K.F.
        • Maddox T.M.
        • Kutty S.
        • Spertus J.A.
        Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: the TRIUMPH Study.
        Nutr Res. 2016; 36: 65-71

      References

        • Bell G.A.
        • Kantor E.D.
        • Lampe J.W.
        • Kristal A.R.
        • Heckbert S.R.
        • White E.
        Intake of long-chain omega-3 fatty acids from diet and supplements in relation to mortality.
        Am J Epidemiol. 2014; 179: 710-720
        • Yamagishi K.
        • Iso H.
        • Date C.
        • et al.
        Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study.
        J Am Coll Cardiol. 2008; 52: 988-996
        • Yuan J.M.
        • Ross R.K.
        • Gao Y.T.
        • Yu M.C.
        Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China.
        Am J Epidemiol. 2001; 154: 809-816
        • Folsom A.R.
        • Demissie Z.
        Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women.
        Am J Epidemiol. 2004; 160: 1005-1010
        • Engeset D.
        • Braaten T.
        • Teucher B.
        • et al.
        Fish consumption and mortality in the European Prospective Investigation into Cancer and Nutrition cohort.
        Eur J Epidemiol. 2015; 30: 57-70
        • Sala-Vila A.
        • Guasch-Ferre M.
        • Hu F.B.
        • et al.
        Dietary alpha-linolenic acid, marine omega-3 fatty acids, and mortality in a population with high fish consumption: findings from the PREvencion con DIeta MEDiterranea (PREDIMED) study.
        J Am Heart Assoc. 2016; 5 (, e002543)
        • Poole C.D.
        • Halcox J.P.
        • Jenkins-Jones S.
        • et al.
        Omega-3 fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study.
        Clin Ther. 2013; 35: 40-51
        • Patel A.Y.
        • Pillarisetti J.
        • Marr J.
        • Vacek J.L.
        Ezetimibe in combination with a statin does not reduce all-cause mortality.
        J Clin Med Res. 2013; 5: 275-280
        • Macchia A.
        • Romero M.
        • D'Ettorre A.
        • Tognoni G.
        • Mariani J.
        Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospective study.
        PLoS One. 2013; 8: e62772
        • Rizos E.C.
        • Ntzani E.E.
        • Bika E.
        • Kostapanos M.S.
        • Elisaf M.S.
        Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
        JAMA. 2012; 308: 1024-1033
        • Casula M.
        • Soranna D.
        • Catapano A.L.
        • Corrao G.
        Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials.
        Atheroscler Suppl. 2013; 14: 243-251
        • Wu J.H.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.
        Circulation. 2014; 130: 1245-1253
        • Warensjo E.
        • Sundstrom J.
        • Vessby B.
        • Cederholm T.
        • Riserus U.
        Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study.
        Am J Clin Nutr. 2008; 88: 203-209
        • Laaksonen D.E.
        • Nyyssonen K.
        • Niskanen L.
        • Rissanen T.H.
        • Salonen J.T.
        Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids.
        Arch Intern Med. 2005; 165: 193-199
        • Mozaffarian D.
        • Lemaitre R.N.
        • King I.B.
        • et al.
        Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
        Ann Intern Med. 2013; 158: 515-525
        • Lindberg M.
        • Saltvedt I.
        • Sletvold O.
        • Bjerve K.S.
        Long-chain n-3 fatty acids and mortality in elderly patients.
        Am J Clin Nutr. 2008; 88: 722-729
        • Harris W.S.
        • Kennedy K.F.
        • O'Keefe Jr., J.H.
        • Spertus J.A.
        Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction.
        Int J Cardiol. 2013; 168: 53-59
        • Pottala J.V.
        • Garg S.
        • Cohen B.E.
        • Whooley M.A.
        • Harris W.S.
        Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul Study.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 406-412
        • Chien K.L.
        • Lin H.J.
        • Hsu H.C.
        • et al.
        Comparison of predictive performance of various fatty acids for the risk of cardiovascular disease events and all-cause deaths in a community-based cohort.
        Atherosclerosis. 2013; 230: 140-147
        • Marklund M.
        • Leander K.
        • Vikstrom M.
        • et al.
        Polyunsaturated fat intake estimated by circulating biomarkers and risk of cardiovascular disease and all-cause mortality in a population-based cohort of 60-year-old men and women.
        Circulation. 2015; 132: 586-594
        • Eide I.A.
        • Jenssen T.
        • Hartmann A.
        • et al.
        The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.
        Clin J Am Soc Nephrol. 2015; 10: 1246-1256
        • Kleber M.E.
        • Delgado G.E.
        • Lorkowski S.
        • Marz W.
        • von Schacky C.
        Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study.
        Atherosclerosis. 2016; 252: 175-181